Investigating this relationship further, a model of anemia at follow-up and the cumulative number of IFA tablets consumed (adjusted for baseline Hb, a squared term of cumulative IFA tablets to account for nonlinearity, demographics, health characteristics, and diet) has good predictive power, with 82.1% AUC (Table 3). This evidence concerns the gene GSTM1 and anemia (phenotype).